Drugs of Abuse Testing
Drug abuse and addiction are top public health concerns with negative consequences for individuals and society. This worldwide epidemic is responsible for tremendous costs and health, social, and community impacts.
Accurate testing is a community’s first line of defense in fighting the drug epidemic, and timely, relevant, and customizable drug testing programs are critical to combating the crisis. Siemens Healthineers, a pioneer in drug testing for over 50 years, has helped nurture and expand the industry by delivering assays that facilitate quality-focused drug testing treatment, harm reduction, and recovery programs.
EMIT, RapidTest, Syva, Viva-ProE, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.
The products/features mentioned here are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
2
https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm SAMHSA (2019). Treatment Episode Data Set
3
(TEDS): Admissions to and Discharges from Publicly-funded Substance Use Treatment